Terms: = Kidney tumors AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
1402 results:
1. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
[TBL] [Abstract] [Full Text] [Related]
3. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
Van Genechten T; De Laere M; Van den Bossche J; Stein B; De Rycke K; Deschepper C; Hazes K; Peeters R; Couttenye MM; Van De Walle K; Roelant E; Maes S; Vanden Bossche S; Dekeyzer S; Huizing M; Caluwaert K; Nijs G; Cools N; Verlooy J; Norga K; Verhulst S; Anguille S; Berneman Z; Lion E
BMJ Open; 2024 Mar; 14(3):e077613. PubMed ID: 38503417
[TBL] [Abstract] [Full Text] [Related]
5. Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis.
Huang RS; Chow R; Chopade P; Mihalache A; Hasan A; Boldt G; Glicksman R; Simone CB; Lock M; Raman S
Radiother Oncol; 2024 May; 194():110216. PubMed ID: 38462092
[TBL] [Abstract] [Full Text] [Related]
6. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S; Bressel M; Sidhom M; Sridharan S; Vanneste BGL; Davey R; Montgomery R; Ruben J; Foroudi F; Higgs B; Lin C; Raman A; Hardcastle N; Hofman MS; De Abreu Lourenco R; Shaw M; Mancuso P; Moon D; Wong LM; Lawrentschuk N; Wood S; Brook NR; Kron T; Martin J; Pryor D;
Lancet Oncol; 2024 Mar; 25(3):308-316. PubMed ID: 38423047
[TBL] [Abstract] [Full Text] [Related]
7. Post Operative Complications Of Open Partial Nephrectomy With Respect To Tumour Location.
Shahzad M; Jamil MN; Ashraf H; Shafique RA; Thaimur MF; Islam EU
J Ayub Med Coll Abbottabad; 2023; 35(3):466-470. PubMed ID: 38404094
[TBL] [Abstract] [Full Text] [Related]
8. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
Wu XW; Zhou PP; Dong Q
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
[TBL] [Abstract] [Full Text] [Related]
9. Long-term outcomes and potential predictive recurrence factors after endonasal endoscopic surgical treatment of symptomatic Rathke's cleft cysts.
Nakase K; Nishimura F; Yokoyama S; Kakutani M; Morisaki Y; Kotsugi M; Takeshima Y; Matsuda R; Young-Soo P; Nakagawa I
Neurosurg Rev; 2024 Feb; 47(1):85. PubMed ID: 38366128
[TBL] [Abstract] [Full Text] [Related]
10. Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.
Chan KH; Li N; Lador R; Amsbaugh M; Gonzalez A; Cen P
J Investig Med High Impact Case Rep; 2024; 12():23247096241231641. PubMed ID: 38344974
[TBL] [Abstract] [Full Text] [Related]
11. Curcumin-loaded pH-sensitive carboxymethyl chitosan nanoparticles for the treatment of liver cancer.
Yang X; Meng D; Jiang N; Wang C; Zhang J; Hu Y; Lun J; Jia R; Zhang X; Sun W
J Biomater Sci Polym Ed; 2024 Apr; 35(5):628-656. PubMed ID: 38284334
[TBL] [Abstract] [Full Text] [Related]
12. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
13. Cemiplimab for kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
[TBL] [Abstract] [Full Text] [Related]
14. Pulmonary metastatectomy in pediatric cancer patients at National Cancer Institute, Egypt: prognostic factors and outcome.
Hamoda A; Elattar I; Mahmoud H; Abdelrahman M; Ebied E
J Egypt Natl Canc Inst; 2024 Jan; 36(1):2. PubMed ID: 38246972
[TBL] [Abstract] [Full Text] [Related]
15. Comparisons of survival and surgical outcomes between minimally invasive partial nephrectomy and radical nephrectomy in elderly patients with stage 1 renal cell carcinoma.
Takagi T; Omae K; Yoshida K; Fukuda H; Kobari Y; Ishihara H; Iizuka J; Kondo T; Ishida H
Geriatr Gerontol Int; 2024 Mar; 24(3):269-274. PubMed ID: 38246656
[TBL] [Abstract] [Full Text] [Related]
16. A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma.
Zalay O; Mehra P; Pereira I; Malone J; Malone S
World J Urol; 2024 Jan; 42(1):52. PubMed ID: 38244135
[TBL] [Abstract] [Full Text] [Related]
17. Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ; Porta C; Eto M; Powles T; Grünwald V; Hutson TE; Alekseev B; Rha SY; Merchan J; Goh JC; Lalani AA; De Giorgi U; Melichar B; Hong SH; Gurney H; Méndez-Vidal MJ; Kopyltsov E; Tjulandin S; Gordoa TA; Kozlov V; Alyasova A; Winquist E; Maroto P; Kim M; Peer A; Procopio G; Takagi T; Wong S; Bedke J; Schmidinger M; Rodriguez-Lopez K; Burgents J; He C; Okpara CE; McKenzie J; Choueiri TK;
J Clin Oncol; 2024 Apr; 42(11):1222-1228. PubMed ID: 38227898
[No Abstract] [Full Text] [Related]
18. Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
Liedberg F; Hagberg O; Aljabery F; Gårdmark T; Jahnson S; Jerlström T; Ströck V; Söderkvist K; Ullén A; Bobjer J
Scand J Urol; 2024 Jan; 59():19-25. PubMed ID: 38226846
[TBL] [Abstract] [Full Text] [Related]
19. Oncological and functional outcomes of patients who underwent open partial nephrectomy for kidney tumor.
Bosnalı E; Baynal EA; Çınar NB; Akdas EM; Telli E; Yaprak Bayrak B; Teke K; Yılmaz H; Dillioğlugil Ö; Kara Ö
Arch Ital Urol Androl; 2023 Dec; 95(4):12130. PubMed ID: 38193219
[TBL] [Abstract] [Full Text] [Related]
20. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
[TBL] [Abstract] [Full Text] [Related]
[Next]
